Repligen reported $7.31M in Interest Income for its fiscal quarter ending in March of 2025.




Interest Income Change Date
Agilent USD 16M 2M Jul/2025
Align Technology USD 5.32M 3.21M Mar/2025
Bio Techne USD 1.03M 322K Mar/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Bruker USD 2.9M 200K Jun/2025
Charles River Laboratories USD 1.1M 307K Jun/2025
Danaher USD 8M 2M Jun/2025
Dentsply International USD 4M 1000K Mar/2025
Exact Sciences USD -5.29 5.08 Dec/2024
General Electric Aerospace USD 173M 173M Mar/2025
Henry Schein USD 9M 3M Jun/2025
Illumina USD 10M 1000K Jun/2025
IQVIA Holdings USD 10M 1000K Jun/2025
Myriad Genetics USD 300K 0 Mar/2025
Pfizer USD 156M 13M Jun/2025
Repligen USD 7.31M 979K Mar/2025
Revvity USD 10.08M 253K Mar/2025
Standard Biotools USD 2.46M 2.46M Jun/2025
Thermo Fisher Scientific USD 203M 24M Mar/2025
Waters USD 4.51M 618K Jun/2025
West Pharmaceutical Services USD 4.1M 700K Mar/2025